Personal or Pro, Dexcom G6 CGM Systems enhances your care.

Dexcom G6 CGM

Dexcom G6 CGM is the first real-time, integrated continuous glucose monitoring (iCGM) system authorized to work with a range of connected insulin pen and hybrid closed-loop system partners.

Insulin pump and pen connections
Adult and pediatric patients ages 2 years+ with type 1 or type 2 diabetes
Comprehensive insights

Dexcom G6 Pro CGM

The Dexcom G6 Pro Continuous Glucose Monitoring (CGM) System is a practice-owned, professional diabetes management tool with the accuracy of the Dexcom G6 CGM System for personal use.

Blinded or unblinded mode  for personalized planning
Patients with or without diabetes
Simplified office workflow

Compare CGM System

Personal or Pro, Dexcom G6 CGM Systems enhances your care.

Accuracy and outcomes

Dexcom CGM use is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.^2,3,10-12

Real-time continuous glucose monitoring (RT-CGM)

Real-time glucose readings are sent straight to your patient's smart device* or receiver whenever, wherever.

ZERO FINGERSTICKS, CALIBRATION, OR SCANS‡

Neither Dexcom G6 Personal nor Pro require calibrations and both can be used to make treatment decisions without fingersticks.

Real-Time Alerts

When the Dexcom G6 Pro is used in unblinded mode, the Urgent Low Soon Alert can warn patients in advance of potentially dangerous low glucose values (55 mg/dL or below) and is associated with reduced hypoglycemia, without a corresponding increase in hyperglycemia.^§,4

REMOTE MONITORING

Your patients can choose to share their glucose data with up to 10^|| followers. Should patients also give their followers the ability to receive alert notifications, followers can help patients stay in range.

Dexcom Clarity compatibility

Use of the Dexcom Clarity software and reports can facilitate better conversations about a patient’s Dexcom G6 glucose data during telehealth or in-person visits.

^‡If your glucose alerts and readings from the Dexcom G6 CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

* Compatible smart devices sold separately: dexcom.com/compatibility.

^† Mean absolute relative difference (MARD) is a statistical measure of accuracy.

^§ This predictive alert can be triggered with impending hypoglycemia (glucose of 55 mg/dL or below is predicted to occur within the next 20 minutes).

^|| Separate Dexcom Follow app required. Internet connectivity required for data sharing. Followers should always confirm readings on the Dexcom G6 app or receiver before making treatment decisions. Followers must have compatible smart devices to use the Dexcom Follow app.

² Beck RW, et al. JAMA. 2017;317(4):371-378.

³ Welsh JB et al. Diabetes Technol Ther. 2019;21(3):128-132.

⁴ Puhr S, et al. Diabetes Technol Ther. 2019;21(4):155-158.

Contact Us

If you are a healthcare provider and want to learn more about Dexcom, please fill out the form and a representative will contact you. If you are a Dexcom User or Patient, please contact Dexcom here.

Request a Visit from a Dexcom Representative

Request a G7 Sample

Request Stelo Education Materials

Please note: To ensure a successful transaction, please provide information that matches the Provider’s medical license information. A valid business address is required for a request to be fulfilled.

Do not include prefix (Mr., Mrs., Dr.)

As listed on Provider’s medical license (no MD, Jr., Sr.)

Please use the Provider's NPI

Please provide the facility address

Is your patient on a connected pump device?

Yes

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense samples of the Dexcom G6 Continuous Glucose Monitoring System and/or Dexcom‘s next generation product, Dexcom G7 (the "Samples"). I represent that I am requesting the Samples for evaluation purposes and that I will not (i) sell, resell, barter, return for credit or seek reimbursement for the use of the Samples, or (ii) for professional services for dispensing or evaluating the Samples, I also agree to inform my patients that they should not submit claims for reimbursement to any third party for any Samples.

The Samples are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither devices nor receivers are included in the Samples. Accordingly, and in light of the applicable G6 or G7 Dexcom Instructions for Use, you should dispense Samples only to a patient who (or whose authorized caregiver), in the exercise of your clinical judgment, (i) has reliable access to a compatible smart device and/or automated insulin delivery system, and (ii) is capable of safely using the Samples with their smart device, without the need for a separate dedicated receiver.

Please note that Medicare will reimburse for sensors only if the beneficiary also uses a receiver covered by Medicare. Accordingly, it is appropriate to give Samples to Medicare patients only if they have (in the case of the G6 Samples) or would be eligible to obtain (in the case of the G7 Samples), a Medicare-covered receiver.

You agree that you will not provide the Samples to any patients that are beneficiaries under the Maine or Colorado state Medicaid programs. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Samples. I agree not to reuse any Samples. I acknowledge that Dexcom provides no warranties for the Samples other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Samples, and I agree to store and use these Samples in a manner consistent with the applicable Dexcom Instructions for Use. Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

LBL-1004145 Rev001

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense these Dexcom G6 Continuous Glucose Monitoring Systems and/or Dexcom‘s next generation product, Dexcom G7 (the "Dexcom Education Devices") which are provided in the quantities listed above.

The Dexcom Education Devices are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither smart devices nor receivers are included with the Dexcom Education Devices. I understand that these Dexcom Education Devices are being requested for me and other healthcare professionals ("HCPs") for evaluation purposes to learn more about the Dexcom Education Devices and experience the benefits of the Dexcom Education Devices through a product demonstration, and that each HCP will need a compatible smart device for the product demonstration.

I acknowledge that Dexcom provides no warranties for the Dexcom Education Devices other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use, and agree not to reuse any Dexcom Education Devices. I agree to receive, store, distribute, and/or use these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use and device labeling. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Dexcom Education Devices. I understand and agree to properly dispose of the Dexcom Education Devices immediately following the completion of the product demonstration. The Dexcom Education Devices are being provided at no cost, without any expectation of remuneration, HCPs have no obligations under the federal supply schedule contract for participating in the product demonstration, and Dexcom waives any rights under this contract or applicable law to pursue a claim for the costs associated with the Dexcom Education Devices.

Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

By choosing to request info, you are granting Dexcom, Inc. permission to process your personal information to send you additional information and promotional communications related to Dexcom products. You may opt-out of these communications at any time. Dexcom respects the privacy and confidentiality of your personal information. The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.

Dexcom G6 and Pro CGM Systems

Dexcom G6 CGM

Dexcom G6 Pro CGM

Personal or Pro, Dexcom G6 CGM Systems enhances your care.

Accuracy and outcomes

Real-time continuous glucose monitoring (RT-CGM)

ZERO FINGERSTICKS, CALIBRATION, OR SCANS‡

Real-Time Alerts

REMOTE MONITORING

Dexcom Clarity compatibility

Contact Us